MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2018 International Congress

    Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

    T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt (Ljubljana, Slovenia)

    Objective: To discriminate among parkinsonian patients using an automated network analysis of FDG-PET brain images. Background: Clinical differentiating among parkinsonian syndromes: Parkinson’s disease (PD), multiple…
  • 2018 International Congress

    A Florbetapir [F18] amyloid PET Imaging study in Parkinson’s disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression

    G. Palermo, G. Aghakhanyan, L. Tommasini, D. Frosini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: To determine whether amyloid deposition, as assessed by PET imaging with the [18F]-Florbetapir, is related in patients with Parkinson Disease and Dementia (PDD) to…
  • 2018 International Congress

    α4β2-nicotinic receptor availability in Parkinson’s disease MCI and healthy controls: A pilot imaging study using [18F]-XTRA PET

    K. Mills, Y. Du, J. Coughlin, A. Horti, M. Pomper, G. Smith (Baltimore, MD, USA)

    Objective: We aimed to show that a radiotracer with high affinity to cortical and hippocampal α4β2-nicotinic cholinergic receptors (1) would be reduced in regions associated…
  • 2018 International Congress

    Dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder

    P. Wu, H. Yu, Z. Huang, C. Zuo (Shanghai, China)

    Objective: This study is to investigate the correlations between the abnormalities in the distribution of striatal dopamine transporter (DAT) and the expression of Parkinson's disease…
  • 2018 International Congress

    Combining PET imaging and blood metabolomics data to improve machine learning models for Parkinson’s disease diagnosis

    E. Glaab, A. Greuel, J.P. Trezzi, C. Jäger, Z. Hodak, L. Timmermann, M. Tittgemeyer, N. Diederich (Esch-sur-Alzette, Luxembourg)

    Objective: To investigate whether the integration of PET imaging and metabolomics data can provide improved machine learning models for PD diagnosis. Background: The reliable diagnosis…
  • 2018 International Congress

    Hypometabolism of the posterior parietal cortex in Parkinson’s disease with mild cognitive impairment predicts the conversion to dementia: 5-year longitudinal observations

    KW. Park, NR. Choi, JH. Ko, SJ. Kim, SJ. Chung, CS. Lee (Seoul, Republic of Korea)

    Objective: To investigate the neuroimaging marker that predict the conversion of mild cognitive impairment (MCI) to dementia in Parkinson’s disease (PD) patients. Background: Patients with…
  • 2018 International Congress

    The role of exposure to pesticides in the etiology of Parkinson’s disease: F-DOPA positron emission tomography study

    R. Djaldetti, A. Steinmetz, A. Rigbi, Y. Roditi, L. Greenbaum, M. Lorberboym (Petah Tiqva, Israel)

    Objective: To examine the pattern of ligand uptake on F-DOPA PET in patients with PD who were exposed or not exposed to pesticides and examine…
  • 2018 International Congress

    Relation of asymmetry of dopamine depletion with motor or non-motor symptoms in patients with Parkinson’s disease: A pilot study

    K.Y. Kwon, J.Y. Lee, K. Im (Seoul, Republic of Korea)

    Objective: This study was aimed to investigate whether asymmetry of dopamine depletion through dopamine transporter (DAT) imaging is associated with motor or non-motor symptoms in…
  • 2018 International Congress

    [11 C] DASB PET imaging in dopa-responsive dystonia patients: The role of serotonin in motor and non-motor symptoms

    E. Timmers, D. Vállez García, A. Bartels, A. Kuiper, R. Dierckx, M. Smit, M. Tijssen (Groningen, Netherlands)

    Objective: To assess the non-displaceable binding potential (BPND) of the serotonin transporter (SERT) in dopa-responsive dystonia (DRD) patients and to determine if an altered BPND…
  • 2018 International Congress

    Functional connectivity changes in relation to dopaminergic decline in Parkinson’s over time: A resting-state fMRI and 11C-PE2I PET imaging study

    W. Li, N. Lao-Kaim, A. Roussakis, A. Martín-Bastida, N. Valle-Guzman, G. Paul, E. Soreq, R. Daws, T. Foltynie, R. Barker, A. Hampshire, P. Piccini (London, United Kingdom)

    Objective: To evaluate the functional connectivity patterns of basal ganglia subdivisions in relation to dopamine transporter density and motor features in patients with PD at…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 40
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley